2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Adenocarcinoma, Papillary in 1 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
Adenocarcinoma, Papillary: An adenocarcinoma containing finger-like processes of vascular connective tissue covered by neoplastic epithelium, projecting into cysts or the cavity of glands or follicles. It occurs most frequently in the ovary and thyroid gland. (Stedman, 25th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yuan, ZQ | 1 |
Sun, M | 1 |
Feldman, RI | 1 |
Wang, G | 1 |
Ma, X | 1 |
Jiang, C | 1 |
Coppola, D | 1 |
Nicosia, SV | 1 |
Cheng, JQ | 1 |
1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Adenocarcinoma, Papillary
Article | Year |
---|---|
Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer.
Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adenosarcoma; Amino Acid Sequence; Apoptosis; B | 2000 |